Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
Indian pharmaceutical organization Strides Pharma Science Ltd said on Thursday it has acquired administrative endorsement to direct clinical preliminaries of antiviral medication favipiravir, a potential treatment for COVID-19.
The organization has gotten endorsement from the Drug Controller General of India to direct preliminaries of favipiravir in the nation, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-income telephone call.
Portions of the organization rose as much as 5.3% to a fourteen day high in early exchange, and were last up 3.5% at 0408 GMT.